RCS - One Health Group PLC - Presentation to Mello2025

One HealthAnnouncement

28/05/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250528:nRSb3026Ka&default-theme=true

RNS Number : 3026K  One Health Group PLC  28 May 2025

 

28 May 2025

 

One Health Group plc

("One Health", the "Company" or the "Group")

Presentation to Mello2025 Investor Event

 

One Health Group plc (AIM: OHGR), an independent provider of NHS-funded
medical procedures, for patients referred through 'Patient Choice' for
treatment in Orthopaedics, Spine, General Surgery, Gynaecology and Urology,
announces that the Company will be presenting and exhibiting at the Mello2025
investor event on Wednesday 4th June 2025, to be held at The Clayton Hotel
& Conference Centre, Chiswick High Road, London, W4 5RY. For further
information visit the event website at www.melloevents.com/mello2025
(https://link.edgepilot.com/s/3c1df8e2/wgcG_RQ1QE2OHYqy6V6j8g?u=http://www.melloevents.com/mello2025)
.

 

The Directors of One Health Group plc accept responsibility for the contents
of this announcement.

 

For more information, please contact:

 

 One Health Group plc                           via Square1 Consulting

 Derek Bickerstaff, Chairman

 Adam Binns, CEO

 Panmure Liberum, Nominated Adviser and Broker  Tel: +44 (0) 20 3100 2000

 Emma Earl, Will Goode, Mark Rogers

 Rupert Dearden

 Square1 Consulting                             Tel: +44 207 929 5599

 David Bick                                     +44 7831 381201

Further information on the Company can be found on its website at
www.onehealth.co.uk (http://www.onehealth.co.uk) .

About One Health Group plc

One Health engages 80 NHS Consultants (excluding anaesthetists) who
sub-specialise in the various surgeries offered by the Company, through a
growing network of community-based outreach clinics and surgical operating
locations. One Health continues to deliver strong growth and, in the year, to
March 2025 provided much needed care to 17,020 new patients, through over
42,000 consultations and over 7,000 surgical procedures. One Health deploys
surgeons and anaesthetists that are mostly employed by the NHS, on a
subcontracted basis. It currently works with over 100 professionals across 9
independent hospitals and 37 outreach clinics. Within these community-based
outreach clinics all consultations and post operative physiotherapy is
delivered where required, reducing patient inconvenience and excess travel.

One Health's activities are focused on areas where NHS patient needs are
under-supplied by the local NHS service, population density is relatively high
and the level of private medical insurance or the ability to self-fund is
relatively low. Currently, the Company's activities are focused in Yorkshire,
Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is
derived from over 60 NHS commissioning bodies in addition to contracts with
local NHS Hospital Trusts to transfer their internal waiting list patients to
One Health for quicker treatment.

One Health's business model has focused to date on four main areas:
orthopaedics, spine, general surgery and gynaecology, with urology introduced
at the end of FY25.

Spine and orthopaedics are particularly attractive areas for One Health as the
Directors believe that they benefit from powerful growth drivers in terms of
an ageing demographic, physical inactivity and an increasing proportion of the
population being categorised as obese. Within orthopaedics, the most common
surgeries performed by One Health are knee and hip replacements.

*(https://www.onehealth.co.uk/investors
(https://www.onehealth.co.uk/investors) )

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRADDLFLEELFBBX